Innovative Technologies for Molecular Analysis of Cancer (R33)

The summary for the Innovative Technologies for Molecular Analysis of Cancer (R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Technologies for Molecular Analysis of Cancer (R33): This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits exploratory grant applications for research projects proposing the development of highly innovative cancer-relevant molecular biology technologies. Technology encompasses methods and tools that enable research, including, but not limited to, instrumentation, techniques, and devices. -This FOA will utilize the NIH Exploratory/Developmental Phase II Grant (R33) award mechanism and runs in parallel with another FOA of identical scientific scope, RFA-CA-07-015, that invites applications under the Exploratory/Developmental Grant (R21) award mechanism. -This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate NIH Guide Notice provides brief cross-comparison and links to all the IMAT FOAs (NOT-CA-06-025). -Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. -The NCI intends to commit a total of up to $1,500,000 to this FOA in fiscal year 2007 to fund up to 4-5 grants. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -Budget and Project Period: An applicant for an R33 grant may request a project period of up to 3 years with a budget appropriate for the science proposed. -Eligible Organizations: For-profit organizations; non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State governments; units of local governments; eligible agencies of the Federal government; domestic institutions; foreign institutions; faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization. -Eligible Project Directors/Principal Investigators (PDs/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct. -Once funded as a PD/PI via this FOA, an individual is then ineligible to submit another application as a PD/PI for this FOA.
Federal Grant Title: Innovative Technologies for Molecular Analysis of Cancer (R33)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-07-016
Type of Funding: Grant
CFDA Numbers: 93.39293.393
CFDA Descriptions: Cancer Construction 93.393 Cancer Cause and Prevention Research
Current Application Deadline: No deadline provided
Original Application Deadline: Sep 22, 2006
Posted Date: May 02, 2006
Creation Date: May 03, 2006
Archive Date: Oct 22, 2006
Total Program Funding: $1,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.394 -- Cancer Detection and Diagnosis Research
Applicants Eligible for this Grant
City or township governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts For profit organizations other than small businesses Native American tribal governments (Federally recognized) Others (see text field entitled "Additional Information on Eligibility" for clarification) State governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional)
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical ...
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Cl...
Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required
Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com